These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 26690777)

  • 1. GPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.
    Vaziri-Gohar A; Houston KD
    Mol Cell Endocrinol; 2016 Feb; 422():160-171. PubMed ID: 26690777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells.
    Vaziri-Gohar A; Zheng Y; Houston KD
    Mol Cancer Res; 2017 Apr; 15(4):489-497. PubMed ID: 28096479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-dependent GPER1 expression modulates tamoxifen-induced IGFBP-1 accumulation.
    Zheng Y; Houston KD
    J Mol Endocrinol; 2019 Aug; 63(2):103-112. PubMed ID: 31242463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation.
    Zheng Y; Sowers JY; Houston KD
    Front Endocrinol (Lausanne); 2020; 11():233. PubMed ID: 32435229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.
    Lee AV; Weng CN; Jackson JG; Yee D
    J Endocrinol; 1997 Jan; 152(1):39-47. PubMed ID: 9014838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line.
    Adamo ML; Shao ZM; Lanau F; Chen JC; Clemmons DR; Roberts CT; LeRoith D; Fontana JA
    Endocrinology; 1992 Oct; 131(4):1858-66. PubMed ID: 1382963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-α36 signaling in vitro.
    Gu W; Dong N; Wang P; Shi C; Yang J; Wang J
    Cell Biol Toxicol; 2017 Apr; 33(2):183-195. PubMed ID: 27837347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
    Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
    Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-concentration BPF induced cell biological responses by the ERα and GPER1-mediated signaling pathways in MCF-7 breast cancer cells.
    Lei B; Huang Y; Liu Y; Xu J; Sun S; Zhang X; Xu G; Wu M; Yu Y; Feng C
    Ecotoxicol Environ Saf; 2018 Dec; 165():144-152. PubMed ID: 30195206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway.
    Martin JL; Baxter RC
    Endocrinology; 2007 May; 148(5):2532-41. PubMed ID: 17289850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
    Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
    Guvakova MA; Surmacz E
    Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein-coupled estrogen receptor is apoptotic and correlates with increased distant disease-free survival of estrogen receptor-positive breast cancer patients.
    Broselid S; Cheng B; Sjöström M; Lövgren K; Klug-De Santiago HL; Belting M; Jirström K; Malmström P; Olde B; Bendahl PO; Hartman L; Fernö M; Leeb-Lundberg LM
    Clin Cancer Res; 2013 Apr; 19(7):1681-92. PubMed ID: 23554355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.